Chronic Thromboembolic Pulmonary Hypertension: Clinical Trials

2 trials for Chronic Thromboembolic Pulmonary Hypertension, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 terminated. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Recruiting 1, Terminated 1

Follow Chronic Thromboembolic Pulmonary Hypertension: new trials by email Literature Review of Chronic Thromboembolic Pulmonary Hypertension trials Research Report on Chronic Thromboembolic Pulmonary Hypertension

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Switching of Sildenafil to Riociguat in CTEPH Patients
Riociguat (Adempas) - Chronic Thromboembolic Pulmonary Hypertension
Phase 4RecruitingChinese University of Hong Kong302024-07-252025-05-29
Effects of Riociguat on RIght VEntricular Size and Function in PAH and CTEPH
Riociguat - Primary Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension
Phase 4TerminatedHeidelberg University302022-04-132026-06-17

Narrower conditions

Pulmonary Arterial Hypertension (1)

Broader conditions

Hypertension, Pulmonary (1)  ·  Lung Diseases (1)  ·  Respiratory Tract Diseases (1)

Interventions

riociguat (2)

Sponsors

Chinese University of Hong Kong (1)  ·  Heidelberg University (1)

Countries

Germany (1)  ·  Hong Kong (1)

Results publications

PMID 41484960, PMID 42538528